ROCK2 and hepatocellular carcinoma: Thus, in the HCC cell models studied, targeting ROCK2 per se is sufficient to downregulate cell growth and migration, as confirmed by miR-139-5p (Figure S4g–l), by siRNA targeting of ROCK2 (Figure S5h), and by chemical inhibition of ROCK2 (Figure S5i,l).